Wednesday, December 23, 2015

"Merck CEO: Major Breakthrough in Lung Cancer Treatment"

Now, a real feel good story.
From Fox Business:
During an interview with the FOX Business Network’s Maria Bartiromo Merck CEO Kenneth Frazier said the company has found, based on new data released over the weekend, how its immune therapy drug Keytruda may help to fight advanced lung cancer.

“This is a new category of drugs that stimulates the body’s immune system,” explained Frazier who singled out the patients who may see the biggest benefit. “With respect to the people who are the sickest lung cancer patients, we now know, using Keytruda will extend their life by approximately 13 months on average. We know that it will reduce the risk of death by 30-40% for people who had failed on standard chemo-therapy.”

He also discussed his outlook for the global economy in 2016....MORE